-

Shareholder Alert: Robbins LLP Announces Aurora Cannabis, Inc. (ACB) Sued for Misleading Shareholders

SAN DIEGO & EDMONTON, Alberta--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a purchaser of Aurora Cannabis, Inc. (NYSE: ACB) filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between October 23, 2018 and January 6, 2020. Aurora produces and distributes medical cannabis products.

If you suffered a loss as a result of Aurora' misconduct, click here.

Aurora Cannabis Inc. (ACB) Accused of Misleading Shareholders

According to the complaint, throughout the relevant period, due to Aurora's exaggerated representation of its market demand, the Company was overproducing consumer use cannabis products, leading to production inefficiencies. As a result, on November 14, 2019, Aurora released dismal fiscal first quarter 2020 financial results that revealed a revenue decline of 24% quarter-over-quarter with net income of $10.4 million, compared to net income of $104.2 million for the same quarter last year. Then, on November 29, 2019, Marijuana Business Daily reported that Germany had stopped the sale of Aurora's medical products while German authorities investigated Aurora's proprietary process. Following these issues, on December 21, 2019, Aurora announced the abrupt departure of its Chief Corporate Officer also described as Aurora's "public face." Finally, as a consequence of its poor financial condition, on January 6, 2020, Aurora announced that it would be selling one of its greenhouses to raise cash, marking the third tangible asset Aurora had decided to offload. Following all of these disclosures, Aurora shares traded at around just $1.83, representing a decline of almost 45% from its closing price of $3.29 on November 14, 2019.

Aurora Cannabis Inc. (ACB) Shareholders Have Legal Options

Contact us to learn more:
Leo Kandinov
(800) 350-6003
lkandinov@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. Click here to receive free alerts from Stock Watch when companies engage in wrongdoing.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
lkandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:ACB

Release Versions
$Cashtags

Contacts

Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
lkandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Shareholder Notice: Robbins LLP Informs Investors of the Lucid Group, Inc. Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Lucid Group, Inc. (NASDAQ: LCID) securities between February 25, 2026 and April 13, 2026. Lucid is a technology company that designs, develops, manufactures, and sells electric vehicles (“EVs”), EV powertrains, and battery systems.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.The Alleg...

Investor Notice: Robbins LLP Informs Investors of the Calix, Inc. Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Calix, Inc. (NYSE: CALX) securities between January 28, 2026 and April 21, 2026. Calix engages in the provision of cloud and software platforms, and systems and services.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.The Allegations: Robbins LLP is Investigating Allegations that Calix,...

Investor Notice: Robbins LLP Informs Investors of the Zoetis Inc. Class Action  

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Zoetis Inc. (NYSE: ZTS) securities between January 14, 2025 and May 6, 2026. Zoetis is an animal health company that develops, manufactures, and sells vaccines, medicines, diagnostics, biopharmaceuticals, and digital solutions for companion animals and livestock.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a...
Back to Newsroom